natgillin/translations-raw huggingface dataset:
Common side effects (affect 1 to 10 people in 100)
Pogosti neželeni učinki (pojavijo se pri 1 do 10 od 100 bolnikov)
• Hot flushes.
• valovi vročine
NAME OF THE MEDICINAL PRODUCT Arimidex and associated names (see Annex I) 1 mg film-coated tablets [See Annex I - To be completed nationally] anastrozole
NAVODILO ZA UPORABO Arimidex in z njim povezana imena (glejte Dodatek I) 1 mg filmsko obložene tablete [Glejte Dodatek I - izpolni država članica] anastrozol
Spine fractures
Zlomi kolka
NAME OF THE MEDICINAL PRODUCT Arimidex and associated names (see Annex I) 1 mg film-coated tablets [See Annex I - To be completed nationally]
Arimidex in z njim povezana imena (glejte Dodatek I) 1 mg filmsko obložene tablete [Glejte Dodatek I - izpolni država članica]
Stop Arimidex if you become pregnant and talk to your doctor.
Če zanosite, nehajte jemati zdravilo Arimidex in se posvetujte z zdravnikom.
BATCH NUMBER Lot
ŠŠKKA AT
Hypercholesterolaemia Very common Headache
Pogosti anoreksija hiperholesterolemija
Disease-free survivala Hazard ratio 2-sided 95% CI
Preživetje brez boleznia Razmerje ogroženosti 2-stranski 95 % IZ
Lactose monohydrate
Mineralna gostota kosti
In a phase III trial (Austrian Breast and Colorectal Cancer Study Group [ABCSG] 8) conducted in 2,579 postmenopausal women with hormone receptor-positive early breast cancer who had received surgery with or without radiotherapy and no chemotherapy (see below), switching to Arimidex after 2 years adjuvant treatment with tamoxifen was statistically superior in disease-free survival when compared to remaining on tamoxifen, after a median follow-up of 24 months.
Pri 2.579 ženskah po menopavzi z zgodnjim rakom dojke in pozitivnimi hormonskimi receptorji je bilo opravljeno preskušanje III. faze (ABCSG [Austrian Breast and Colorectal Cancer Study Group] 8).
Joint pain/stiffness
Bolečine v sklepih/togost
Fractures
Odmerjanje
Hepatic impairment
• izguba teka
BEFORE YOU TAKE ARIMIDEX
KAJ MORATE VEDETI, PREDEN BOSTE VZELI ZDRAVILO ARIMIDEX
• Being sick (vomiting).
• slabost v želodcu (siljenje na bruhanje)
This normally takes several seconds.
Za to je običajno potrebnih nekaj sekund.
You could put yourself or others at risk of serious injury or death.
V nasprotnem primeru lahko sebe ali druge spravite v nevarnost za resno poškodbo ali smrt.
c p-value for PGI-C is nominal.
c Vrednost p za PGI-C je nominalna.
Results are presented in Table 2.
Rezultati so predstavljeni v preglednici 2.
For more information see section 4.
Za več informacij glejte poglavje 4.
Do not push the handle and mouthpiece together more than once.
Ustnika in držaja ne stisnite skupaj več kot enkrat.
Most of the gender difference is accounted for by differences in body weight.
Večina razlike med spoloma je razložljiva z razlikami v telesni masi.
Find a clean and dry surface.
Poiščite čisto in suho površino.
Godfried Bomansstraat 31 6543 JA Nijmegen Netherlands
Godfried Bomansstraat 31 6543 JA Nijmegen
This may cause difficulties in breathing or swallowing.
To lahko povzroči težave pri dihanju ali požiranju.
This reaction will not be altered by boiling the urine specimen.
Ta reakcija se ne spremeni s prevretjem vzorca urina.
This is because the medicine may affect the results of some tests.
To je zato, ker lahko to zdravilo vpliva na rezultate nekaterih preiskav.
Make sure your hands are clean and dry.
Poskrbite, da bodo vaše roke čiste in suhe.
Your doctor may need to review your treatments.
Zdravnik bo morda moral znova oceniti vaše zdravljenje.
Patients should be monitored and supportive care should be provided.
Bolnike je treba spremljati in jim zagotoviti podporno oskrbo.
Take in a deep, comfortable breath until your lungs feel full.
Globoko in udobno vdihnite, dokler ne začutite, da so se vaša pljuča napolnila.
• Make sure your hands are clean and dry when using the inhaler and capsules.
• Poskrbite, da bodo vaše roke čiste in suhe, ko uporabljate inhalator in kapsule.
Much improved % (n) Improved % (n) Little improved % (n) Not improved % (n) p-value
% z velikim izboljšanjem (n) % z izboljšanjem (n) % z majhnim izboljšanjem (n) % brez izboljšanja (n)
Other side effects you may experience of which the frequency is not known include:
Drugi neželeni učinki, ki se lahko pojavijo, njihova pogostnost pa ni znana, vključujejo:
- Your doctor or pharmacist will show you how to use your medicine correctly.
- Zdravnik ali farmacevt vam bo pokazal, kako pravilno uporabljati vaše zdravilo.
2 doses a Observed cases.
2 odmerka a Opaženi primeri.
Patients who are taking these medicinal products should be monitored closely.
Bolnike, ki jemljejo ta zdravila, je treba natančno spremljati.
You may feel confused or agitated, and your heart rate may be slower or faster than normal.
Morda se boste počutili zmedene ali nemirne in vaš srčni utrip bo morda hitrejši ali počasnejši kot običajno.
After 12 months, the average reduction in FEV1 from baseline was the same in both groups (-0.1 L).
Po 12 mesecih je bilo povprečno zmanjšanje FEV1 v primerjavi z izhodiščem v obeh skupinah enako (-0,1 l).
During off periods your usual medicine does not control the condition well enough and movement is likely to be more difficult.
obdobjih izklopa pa vaše običajno zdravilo ne obvladuje bolezni dovolj dobro in vaše gibanje je verjetno oteženo.
• It is normal for some powder to remain on the inhaler.
• Normalno je, da na inhalatorju ostane nekaj praška.
There is only limited data available in very elderly patients (≥75 years).
Podatki za zelo stare bolnike (≥ 75 let) so omejeni.
The mouthpiece will spring back and stay attached.
Ustnik bo zdrsnil nazaj in ostal pritrjen.
Daily doses (median)
Dnevni odmerki (mediana)
% (n) Diff. p-value
% (n) Razlika vrednost p
Do not use any capsule that looks crushed, damaged or wet.
Nikoli ne uporabite kapsule, če je videti zdrobljena, poškodovana ali vlažna.
If the off period has passed, do not use Inbrija until the next off period.
Če je obdobje izklopa že minilo, ne uporabljajte zdravila Inbrija do naslednjega obdobja izklopa.
You can use 2 capsules up to five times a day.
Dve kapsuli smete uporabiti največ petkrat na dan.
do not drive or use tools or machines.
Če se to zgodi vam, ne vozite in ne uporabljajte orodij ali strojev.
Please see the “Instructions for use” at the end of this leaflet on how to use your medicine with the provided inhaler.
Glejte poglavje »Navodila za uporabo« na koncu tega navodila za uporabo, kjer je razloženo, kako morate uporabljati svoje zdravilo s priloženim inhalatorjem.
Subjects had to be able to recognise OFF periods and to handle the device.
Udeleženci so morali biti sposobni prepoznati epizode izklopa in ravnati s pripomočkom.
Important: If you did not hear or feel the capsule “whirl” while inhaling you may need to take a deeper, longer breath.
Pomembno: Če niste čutili ali slišali, da se kapsula med inhaliranjem »vrti«, boste morda morali narediti globlji in daljši vdih.
Detailed instructions for use for the patients are included in the package leaflet.
Podrobna navodila za uporabo za bolnike so vključena v priloženo navodilo za uporabo.
Concurrent use can, however, cause a worsening of involuntary motor disorders.
Vendar pa lahko sočasna uporaba povzroči poslabšanje nehotenih motoričnih motenj.
Malaise,
srbenje,
Frequency categories are defined as follows: very common (≥1/10), common (≥1/100 to <1/10), not known
Kategorije pogostnosti so opredeljene po naslednjem dogovoru: zelo pogosti (≥1/10), pogosti (≥1/100 to <1/10), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
The maximum daily dose of Inbrija should not exceed 10 capsules (330 mg).
Največji dnevni odmerek zdravila Inbrija ne sme preseči 10 kapsul (330 mg).
Epidemiological studies have shown that patients with Parkinson's disease have a higher risk (2- to approximately 6-fold higher) of developing melanoma than the general population.
Epidemiološke študije so pokazale, da imajo bolniki s Parkinsonovo boleznijo v primerjavi s splošno populacijo večje tveganje za razvoj melanoma (2-krat do približno 6-krat večje).
Prepare your dose
Pripravite svoj odmerek
No dose adjustment is required based on smoking status.
Prilagoditev odmerka glede na status kadilca ni potrebna.
Puncturing tines and springs are made from stainless steel.
Igle in vzmeti za prebadanje so izdelane iz nerjavečega jekla.
2 doses
2 odmerka
Do not breathe into mouthpiece.
Ne dihajte v ustnik.
In addition, certain medicinal products used to treat psychosis may exacerbate the symptoms of Parkinson's disease and may decrease the effectiveness of levodopa.
Poleg tega lahko določena zdravila za zdravljenje psihoze poslabšajo simptome Parkinsonove bolezni in zmanjšajo učinkovitost levodope.
Duration PD
Trajanje PB
Local or systemic pulmonary medicinal products
Lokalna ali sistemska zdravila za pljuča
You must stop taking these medicines at least 14 days before starting treatment with Inbrija.
Ta zdravila morate nehati jemati vsaj 14 dni pred začetkom zdravljenja z zdravilom Inbrija.
Line up the white arrows on the handle and mouthpiece.
Poravnajte beli puščici na držaju in ustniku.
Dispose of used capsules in accordance with local requirements.
Uporabljene kapsule odstranite v skladu z lokalnimi zahtevami.
Dispose of it and get a new capsule.
Zavrzite jo in vzemite novo kapsulo.
UPDRS-III was assessed before and 30 minutes post dose administration.
UPDRS-III so ocenili pred dajanjem odmerka in 30 minut po njem.
Central Nervous System (CNS) effects and mental disturbances
Učinki na osrednji živčni sistem (OŽS) in duševne motnje
Patients selected for treatment with Inbrija should be able to recognize the onset of their 'OFF' symptoms and be capable of preparing the inhaler or else have a responsible care giver able to prepare the inhaler for them when required.
Bolniki, ki so izbrani za zdravljenje z zdravilom Inbrija, morajo biti sposobni prepoznati nastop svojih simptomov »izklopa« in zmožni pripraviti inhalator oziroma morajo imeti odgovornega skrbnika, ki bo zanje pripravil inhalator, ko bo to potrebno.
Do not use Inbrija if you have taken medicines called non-selective MAO inhibitors for treating depression in the last 14 days.
Ne uporabljajte zdravila Inbrija, če ste v zadnjih 14 dneh vzeli zdravila, imenovana neselektivni zaviralci MAO, za zdravljenje depresije.
• Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.
ob vsakršni spremembi sistema za obvladovanje tveganj, zlasti kadar je tovrstna sprememba posledica prejema novih informacij, ki lahko privedejo do znatne spremembe razmerja med koristmi in tveganji, ali kadar je ta sprememba posledica tega, da je bil dosežen pomemben mejnik (farmakovigilančni ali povezan z zmanjševanjem tveganja).
The following side effects may happen with this medicine: Very common (may affect more than 1 in 10 people): - cough
Pri tem zdravilu se lahko pojavijo naslednji neželeni učinki: Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 oseb):
There are no data on the effects of levodopa on human fertility.
Ni podatkov o vplivu levodope na plodnost pri človeku.
Tell your doctor or pharmacist if you are taking:
Obvestite zdravnika ali farmacevta, če jemljete:
Sudden onset of sleep during daily activities, in some cases without awareness or warning signs, has been reported very rarely.
Zelo redko so poročali o nenadnem nastopu spanca med dnevnimi dejavnostmi, v nekaterih primerih brez zavedanja ali opozorilnih znakov.
Furthermore, a reduction of dose or termination of therapy may be considered.
Treba je tudi razmisliti o zmanjšanju odmerka ali ukinitvi zdravljenja.
These may be symptoms of “withdrawal-emergent hyperpyrexia”.
To so lahko simptomi »hiperpireksije ob odtegnitvi«.
After administration of Inbrija the Cmax and AUC0-24 h was 11% to 12% higher for smokers than for non-smokers.
Po aplikaciji zdravila Inbrija sta bili Cmax in AUC0-24 h pri kadilcih 11 % do 12 % večji kot pri nekadilcih.
The most frequent adverse reactions reported in the Inbrija clinical studies were cough (15.6%), fall (8.7%), upper respiratory tract infection (5.8%), dyskinesia (5.7%) and sputum discoloured (2.8%).
Najpogostejši neželeni učinki, o katerih so poročali v kliničnih študijah z zdravilom Inbrija, so bili kašelj (15,6 %), padec (8,7 %), okužba zgornjih dihal (5,8 %), diskinezija (5,7 %) in sprememba barve sputuma (2,8 %).
If you cough or stop your dose, start again from the beginning of Step 7 using the same capsule.
Če zakašljate ali prekinete svoj odmerek, ponovno začnite s 7. korakom, pri čemer uporabite isto kapsulo.
The European Medicines Agency has waived the obligation to submit the results of studies with Inbrija in all subsets of the paediatric population in the treatment of idiopathic Parkinson's disease (see section 4.2 for information on paediatric use).
Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom Inbrija za vse podskupine pediatrične populacije za zdravljenje idiopatske Parkinsonove bolezni (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
Tricyclic antidepressants
Triciklični antidepresivi
The physician or other healthcare professional should instruct the patient how to administer the product correctly.
Zdravnik ali drug zdravstveni delavec mora bolnika podučiti, kako se pravilno jemlje zdravilo.
Use one capsule at a time.
Uporabite eno kapsulo naenkrat.
See also under “Other medicines and Inbrija”.
Glejte tudi poglavje »Druga zdravila in zdravilo Inbrija«.
Your doctor will monitor you closely during start of treatment; - an ulcer in your stomach or intestines; - an eye condition called glaucoma, because the pressure in your eyes may need to be monitored; - severe problems with your kidneys; - severe problems with your liver.
Zdravnik vas bo ob začetku zdravljenja natančno spremljal; - razjeda/čir v želodcu ali črevesju; - bolezen oči, imenovana glavkom, saj bo morda treba spremljati tlak v vaših očeh; - hude težave z ledvicami; - hude težave z jetri.
Any nonselective MAO inhibitors should be discontinued at least 14 days prior to initiating levodopa.
Vse neselektivne zaviralce monoaminooksidaze je treba ukiniti vsaj 14 dni pred uvedbo levodope.
This may damage the capsule, and you may not get your full dose.
To bi lahko povzročilo poškodbo kapsule in preprečilo, da bi prejeli celoten odmerek.
Alanine aminotransferase increased,
povečana alanin aminotransferaza,
If you need to have surgery, tell your doctor that you are using Inbrija.
Če boste potrebovali kirurški poseg, povejte zdravniku, da uporabljate zdravilo Inbrija.
Concomitant use of antipsychotics should be monitored carefully for worsening of Parkinson's motor symptoms especially when D2-receptor antagonists are used (see section 4.5).
Pri sočasni uporabi antipsihotikov je potrebno skrbno spremljanje glede poslabšanja motoričnih simptomov Parkinsonove bolezni, še posebej, kadar se uporabljajo antagonisti receptorjev D2 (glejte poglavje 4.5).
Abnormalities in blood urea nitrogen (BUN) and positive Coombs test have also been reported.
Poročali so tudi o anomalijah pri dušiku sečnine v krvi (BUNblood urea nitrogen) in o pozitivnem Coombsovem testu.
Levodopa is associated with somnolence and has been associated very rarely with excessive daytime somnolence and sudden sleep onset episodes.
Levodopa je povezana s somnolenco in so jo zelo redko povezali s prekomerno somnolenco v dnevnem času ter epizodami nenadnega nastopa spanca.
You will need it later to store the inhaler.
Ponovno ga boste potrebovali, da boste pospravili inhalator.
Step 9: Hold breath for 5 seconds, then breathe out
9. korak: Zadržujte dih v pljučih 5 sekund in nato izdihnite.
The maximum dose of Inbrija is 10 capsules per day.
Največji odmerek zdravila Inbrija je 10 kapsul na dan.
The whirl means the inhaler is working and you are getting your medicine.
To vrtenje pomeni, da inhalator pravilno deluje in da inhalirate svoje zdravilo.
Whether the increased risk observed was due to Parkinson's disease or other factors, such as medicinal products used to treat Parkinson's disease, is unclear.
Ni jasno, ali je opaženo večje tveganje posledica Parkinsonove bolezni ali drugih dejavnikov, na primer zdravil za zdravljenje Parkinsonove bolezni.
Table 2: Baseline features and results of the efficacy endpoints Parameters
Preglednica 2: Izhodiščne lastnosti in rezultati opazovanih dogodkov učinkovitosti
Then breathe out.
Nato izdihnite.
You should continue taking your main medicine for Parkinson's disease and use Inbrija to control worsening of symptoms (such as inability to move) during off periods.
Še naprej morate jemati svoje glavno zdravilo za Parkinsonovo bolezen, zdravilo Inbrija pa uporabljajte za obvladovanje poslabšanja simptomov (npr. nezmožnosti premikanja) v obdobjih izklopa.
Your inhaler is now ready to use.
Vaš inhalator je sedaj pripravljen za uporabo.
The safety and efficacy of Inbrija in children under 18 years of age have not been established.
Pediatrična populacija Varnost in učinkovitost zdravila Inbrija pri otrocih, mlajših od 18 let, nista bili dokazani.
Using more than one dose of Inbrija (2 capsules) to treat the same OFF period may result in CNS disturbances, with an increasing likelihood of cardiovascular disturbance (e.g. hypotension, tachycardia) and more severe psychiatric problems at higher doses.
Uporaba več kot enega odmerka zdravila Inbrija (2 kapsuli) za zdravljenje istega obdobja izklopa lahko povzroči motnje osrednjega živčnega sistema, pri čemer se pri večjih odmerkih poveča verjetnost kardiovaskularnih motenj (npr. hipotenzije, tahikardije) in resnejših psihiatričnih motenj.
You may experience the following side effects:
Pojavijo se lahko tudi naslednji neželeni učinki:
Pulmonary function was assessed by spirometry and carbon monoxide diffusing capacity (DLCO) every 3 months in both groups.
Pljučno funkcijo so v obeh skupinah vsake 3 mesece ocenili prek spirometrije in difuzne kapacitete pljuč za ogljikov monoksid (DLCO).
Pharmacotherapeutic group: Anti-Parkinson drugs, dopaminergic agents, ATC code: N04BA01 Mechanism of action
Farmakoterapevtska skupina: antiparkinsoniki, dopaminergiki, oznaka ATC: N04BA01
What Inbrija is and what it is used for
Kaj je zdravilo Inbrija in za kaj ga uporabljamo
b A responder was defined as a subject that changed from OFF to ON within 60 minutes post dose and who remained ON at 60 minutes post dose.
b Odziven bolnik je bil opredeljen kot udeleženec, ki je v 60 minutah po odmerjanju prešel iz izklopa v vklop in ostal v stanju vklopa 60 minut po odmerjanju.
If an OFF period emerged subjects received placebo or inhaled levodopa.
Če je nastopilo obdobje izklopa, so udeleženci prejeli placebo ali inhalirano levodopo.
Patients being treated with levodopa medicinal products and presenting with somnolence and/or sudden sleep episodes must be informed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e.g. use machines), until such recurrent episodes and somnolence have resolved (see also section 4.4).
Bolnike, ki se zdravijo z levodopo in se pri njih pojavijo somnolenca in/ali epizode nenadnega spanca, je treba obvestiti, da ne smejo voziti ali izvajati dejavnosti, pri katerih bi lahko zmanjšana pozornost njih ali druge izpostavila resnemu tveganju ta poškodbe ali smrt (npr. uporaba strojev), dokler tovrstne ponavljajoče se epizode in somnolenca ne izzvenijo (glejte tudi poglavje 4.4).
Patients who have experienced somnolence and/or an episode of sudden sleep onset must refrain from driving or operating machines.
Bolniki, pri katerih se pojavi somnolenca in/ali epizoda nenadnega nastopa spanca, ne smejo voziti ali upravljati strojev.
Place the mouthpiece and inhaler on a clean and dry surface.
Ustnik in inhalator položite na čisto in suho površino.
97 months
97 mesecev
After administration of Inbrija the Cmax and AUC0-24 h for women were 42.2% higher and 48.8% higher than for men, respectively.
Po aplikaciji zdravila Inbrija sta bili Cmax in AUC0-24 h pri ženskah 42,2 % oziroma 48,8 % večji kot pri moških.
- if you get blurred vision, red eyes, severe eye and head pain, halos around lights, pupils of your eyes that are larger than normal size and feel sick.
- če se pri vas pojavijo zamegljen vid, rdeče oči, huda bolečina v očeh in glavi, kolobarji okoli luči, bolj razširjene zenice kot običajno in siljenje na bruhanje.
Patients must be informed of this and advised to exercise caution while driving or operating machines during treatment (see section 4.7).
Bolnike je treba s tem seznaniti in jim svetovati previdnost pri vožnji ali upravljanju strojev med zdravljenjem (glejte poglavje 4.7).
Prepare and use a total of 2 capsules.
Pripravite in uporabite skupno 2 kapsuli.
Based on individual assessments of the severity of the intercurrent respiratory infection Inbrija may be continued or discontinued until the respiratory symptoms resolve (see section 4.2).
Na podlagi individualne ocene resnosti sočasne okužbe dihal se je mogoče odločiti za nadaljevanje ali prekinitev zdravljenja z zdravilom Inbrija do razrešitve dihalnih simptomov (glejte poglavje 4.2).
No dose adjustment is required based on gender.
Prilagoditev odmerka glede na spol ni potrebna.
Take your dose
Vzemite svoj odmerek.
Start again from the beginning of Step 7 using the same capsule.
Ponovno začnite s 7. korakom, pri čemer uporabite isto kapsulo.
The maximum time between inhalation of the powder from the first and second capsules should not exceed 10 minutes.
Čas, ki preteče med inhalacijo praška iz prve kapsule in inhalacijo praška iz druge kapsule, ne sme preseči 10 minut.
Levodopa has caused visceral and skeletal malformations in rabbits.
Levodopa je pri kuncih povzročila visceralne in skeletne malformacije.
These inhibitors should already be discontinued for at least two weeks prior to initiating therapy due to the established underlying levodopa therapy (see section 4.5).
Ti zaviralci bi morali biti ukinjeni vsaj dva tedna pred uvedbo zdravljenja s tem zdravilom zaradi uveljavljenega osnovnega zdravljenja z levodopo (glejte poglavje 4.5).
Coombs test positive, White blood cells urine positive,
pozitiven Coombsov test, pozitiven test na bele krvničke
After correcting the parameters for body weight, the gender difference after each treatment was no longer significant: the body-weight adjusted Cmax and AUC0-24 h after a dose of Inbrija in women were 9.7% and 15.1% higher than men.
Po korekciji parametrov za telesno mase razlika med spoloma po vsakem zdravljenju ni bila več značilna; glede na telesno maso prilagojeni Cmax in AUC0-24 h po odmerku zdravila Inbrija pri ženskah sta bili 9,7 % in 15,1 % večji kot pri moških.
A dose adjustment of levodopa may be required.
Lahko je potrebna prilagoditev odmerka levodope.
Patients who are taking these medicinal products should be monitored for worsening Parkinson's symptoms (see section 4.4).
Bolnike, ki jemljejo ta zdravila, je treba spremljati glede poslabšanja simptomov Parkinsonove bolezni (glejte poglavje 4.4).
Close your lips firmly around the mouthpiece and breathe in, again holding your breath for 5 seconds.
Tesno sklenite ustnice okoli ustnika ter vdihnite in ponovno zadržite dih v pljučih 5 sekund.
As you breathe in, you will hear and feel the capsule “whirl” (spin).
Med vdihom boste čutili in slišali, da se kapsula »vrti« (obrača).
Levodopa may cause a false-positive reaction for urinary ketone bodies when a test tape is used for determination of ketonuria.
Levodopa lahko povzroči lažno pozitivno reakcijo na ketonska telesa v urinu pri uporabi testnega traku za ugotavljanje ketonurije.